# A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding

> **NCT03983707** · — · COMPLETED · sponsor: **Portsmouth Hospitals NHS Trust** · enrollment: 379 (actual)

## Conditions studied

- Gastrointestinal Bleeding
- Delayed Bleeding

## Interventions

- **DEVICE:** Purastat®

## Key facts

- **NCT ID:** NCT03983707
- **Lead sponsor:** Portsmouth Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-23
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-10-31
- **Target enrollment:** 379 (ACTUAL)
- **Last updated:** 2025-05-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03983707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03983707, "A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT03983707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*